Clinical trials in Moenchengladbach

Clinical research in Mönchengladbach is strongly focused on neoplasms, with studies in acute myeloid leukemia and several forms of breast cancer. These trials are looking at whether new treatment combinations can improve disease control, reduce recurrence, and support better outcomes for patients with early and advanced cancer.

• Testing a new approach for acute myeloid leukemia
• Evaluating treatment effectiveness in HER2-positive breast cancer
• Studying options for advanced HER2-negative, hormone receptor positive breast cancer
• Assessing strategies to improve recurrence-free survival and long-term cancer control

The oncology portfolio includes both therapy-focused and biology-driven research, helping refine how cancer is treated in real-world settings.

Research in cardiovascular diseases includes studies for chronic heart failure with reduced ejection fraction. These trials are designed to evaluate whether new treatments can lower the risk of hospitalization and cardiovascular death while improving day-to-day heart function.

• Studying heart failure treatment effectiveness
• Evaluating reduction in cardiovascular death
• Assessing prevention of heart failure hospitalization

This area reflects a practical effort to improve care for people living with serious long-term heart disease.

A notable part of the clinical trial activity addresses virus diseases, especially RSV and meningococcal infection. The studies are centered on vaccine performance, safety, and immune response, with the aim of strengthening prevention in infants, children, adolescents, and healthy volunteers.

• Testing RSV vaccination to prevent lower respiratory tract disease
• Evaluating meningococcal vaccines in children and adolescents
• Studying immune response and protection after booster doses
• Including healthy volunteers in prevention-focused research

These trials support better vaccination strategies and help clarify how long immune protection lasts.

Trials in respiratory tract diseases focus on respiratory tract infections with wheezing lower respiratory illness in young children. The main goal is to test whether preventive treatment can reduce the number of infections and ease the burden of recurring respiratory illness.

• Studying prevention of recurrent respiratory tract infections
• Evaluating treatment for wheezing lower respiratory illness
• Measuring reduction in infection frequency in children

This research is especially relevant for families seeking better options for children with repeated breathing-related infections.

The local research portfolio also includes skin and connective tissue diseases, such as actinic keratosis and candidiasis of the skin. These studies are examining whether topical treatments can clear lesions, control inflammation, and improve outcomes for patients with fungal or pre-cancerous skin conditions.

• Testing therapy for actinic keratosis of the scalp and face
• Assessing treatment for inflamed candidiasis of the skin
• Comparing topical options for symptom relief and lesion clearance

This field combines symptom control with efforts to improve visible skin healing and treatment response.

Clinical studies in bacterial infections and mycoses cover prevention and treatment of infections involving meningococcal disease, pneumococcal immunization, and candidiasis. The research is largely vaccine- and treatment-oriented, aiming to improve protection and manage common infectious risks.

• Evaluating protection against meningococcal infection
• Studying pneumococcal immunization in infants
• Assessing treatment for skin fungal infections

These trials help strengthen both infection prevention and practical treatment options across different age groups.